Compare CLW & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLW | CUVL |
|---|---|---|
| Founded | 1926 | 1999 |
| Country | United States | Australia |
| Employees | 3710 | 16 |
| Industry | Paper | Miscellaneous |
| Sector | Basic Materials | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.7M | 374.2M |
| IPO Year | 2008 | N/A |
| Metric | CLW | CUVL |
|---|---|---|
| Price | $19.04 | $5.00 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $22.25 | N/A |
| AVG Volume (30 Days) | ★ 98.7K | 4.9K |
| Earning Date | 10-26-2026 | 08-27-2026 |
| Dividend Yield | N/A | ★ 0.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,555,400,000.00 | N/A |
| Revenue This Year | N/A | $0.89 |
| Revenue Next Year | $4.20 | $6.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.42 | N/A |
| 52 Week Low | $11.73 | $4.91 |
| 52 Week High | $23.59 | $8.20 |
| Indicator | CLW | CUVL |
|---|---|---|
| Relative Strength Index (RSI) | 45.61 | 30.44 |
| Support Level | $18.13 | $4.91 |
| Resistance Level | $19.09 | $6.04 |
| Average True Range (ATR) | 0.77 | 0.15 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 42.98 | 10.09 |
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.
Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.